Xconomy

SEPTEMBER 15, 2016

San Diego’s innovation clusters continued to grow in 2015, as local startups, funding deals, and job growth extended an economic growth spurt that began in 2013. That’s according to a report being released today by Connect, the local nonprofit group focused on technology and entrepreneurship.

San Diego 40

San Diego Report High Tech Study 40

Xconomy

JUNE 23, 2016

San Diego’s cybersecurity workforce has grown by nearly 15 percent over the past two years, according to a study released today by the Cyber Center of Excellence, a nonprofit industry group created to boost cybersecurity jobs and technologies in the region. The center also asked the San Diego Regional Economic Development Corp.

San Diego 69

San Diego Study Outsource Development Report 69

Xconomy

APRIL 5, 2019

—Mobile app startup Bitmo announced it had raised more than $3 million in seed funding from investors including Everplus Capital, Longboard Capital Advisors, and several Southern California-based family fund offices. Bitmo’s mobile app allows users to send and receive digital gift cards that can be switched between a number of stores.

San Diego 74

San Diego Seed Funding Southern California Report 74

Xconomy

APRIL 6, 2017

Thirty-seven venture-backed companies in the San Diego area collected almost $350 million in new funding during the first three months of 2017, according to data released this week as part of the latest Venture Monitor report from the National Venture Capital Association and Seattle-based PitchBook.

San Diego 61

San Diego Venture Capital Funding Invest 61

Xconomy

OCTOBER 10, 2017

The San Diego artificial intelligence company Brain Corp. topped the chart for raising the most venture capital in San Diego during the third quarter that ended September 30, according to Venture Monitor data released Tuesday. As Xconomy reported in July, Brain Corp.

San Diego 48

San Diego Venture Capital Artificial Inteligence Funding 48

Xconomy

JULY 17, 2016

After the national MoneyTree Report was released last week, PricewaterhouseCoopers partner Ryan Spencer said he spent time on a call with Thomson Reuters, which provides the raw data, trying to figure out a change in the numbers for venture capital activity in San Diego. But the San Diego data was off. Of the $350.5

San Diego 40

San Diego Venture Capital Funding Report 40

Xconomy

OCTOBER 11, 2016

Venture Capital investments in San Diego startups fell by roughly a third during the three months that ended September 30, according to data released recently by Seattle-based PitchBook and the National Venture Capital Association. As Xconomy reported last week , third-quarter venture funding also slipped nationwide to $14.99

San Diego 40

San Diego Venture Capital Startup Report 40

Both Sides of the Table

OCTOBER 19, 2009

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.

Venture Capital 274

Venture Capital Blogging Startup Slides 274

Xconomy

NOVEMBER 13, 2016

I started with a list of companies already screened by the San Diego Venture Group’s annual venture summit, and consulted with investors and startup mentors to refine the list. Tim Rueth, a UC San Diego entrepreneur in residence and member of the EvoNexus selection committee, also screened the list, and offered his perspective.

San Diego 40

San Diego Technical Review Artificial Inteligence Startup 40

Xconomy

JANUARY 14, 2019

Read Xconomy’s annual reporter’s notebook-style JPM. Francis Hotel, says long-time conference attendee Joe Panetta, president and CEO of California’s Biocom, who returned this year for the 37th annual. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 65

San Diego Company Companies Conference 65

Xconomy

AUGUST 11, 2020

San Diego-based Ligand (NASDAQ: LGND ) generates revenue from licensing deals and royalties paid by pharmaceutical companies that use technologies it develops or acquires for their own drug research. The company reported revenues of about $120.3 million in 2019.

San Diego 98

San Diego Technology Research Pricing 98

Xconomy

APRIL 23, 2019

In this Xconomy Special Report , our veteran technology journalists Bernadette Tansey, David Holley, and I bring you deep insights from key industry leaders and observers about what the future holds for.

Report 98

Report Pricing Organization Technology 98

Xconomy

MARCH 15, 2019

A global pharmaceutical company based in France has licensed software developed by San Diego digital health startup CureMatch that aims to help cancer doctors customize the combination of drugs they prescribe to patients based on mutations in cancer DNA. It calls the guides it produces PreciGENE reports.

Customer 76

Customer Custom San Diego Guide 76

Xconomy

JANUARY 28, 2020

The audit, tax, and advisory services firm shared details of the trend in its Healthcare & Life Sciences Outlook report, explaining that for companies developing cell, gene, and nucleic acid-based therapies, innovation is a necessity. “As KPMG says companies that choose to own the whole spectrum of R&D and manufacturing can.

Report 89

Report Services Develop Development 89

Xconomy

MARCH 1, 2019

In this Xconomy Special Report, our veteran biotech journalists Alex Lash and Ben Fidler bring you deep insights, based on conversations with key industry leaders, on what 2019 and beyond hold for biopharmaceutical companies. In this Report, you’ll learn: The key indicators that suggest a possible downturn is on the way.

Report 83

Report Pricing Sales San Diego 83

Xconomy

MAY 18, 2017

Preliminary findings from an economic impact study show that genomics is emerging as a distinct innovation cluster in San Diego. The San Diego Regional Economic Development Corp. began collecting data for the report earlier this year in a bid to assess how genomics fits into San Diego’s innovation economy.

Study 97

Study San Diego Venture Capital Press 97

Xconomy

MARCH 24, 2017

Roughly seven months after Intel (NASDAQ: INTC ) acquired San Diego-based Nervana Systems, the chipmaker is consolidating its portfolio of artificial intelligence businesses in one group, headed by former Nervana CEO Naveen Rao. Rao plans to remain in San Diego, according to a spokeswoman for Intel Nervana.

Artificial Inteligence 40

Artificial Inteligence San Diego Blogging Writing 40

socalTECH

MARCH 16, 2012

San Diego-based Givit , the online video sharing service kicked off by VMIX Thursday, reported last night that it is seeing "temporary delays" due to overwhelming demand for the service. The company said, in a blog post, that the response was "overwhelming" for the service, which caused its services to be a "little slow".

San Diego 145

San Diego Blogging Demand Services 145

Xconomy

JULY 21, 2020

Since then, the San Diego company has looked to expand its use into other indications, with mixed results. Acadia Pharmaceuticals received the FDA’s OK for pimavanserin (Nuplazid), the first drug approved to treat hallucinations and delusions associated with Parkinson’s disease , in 2016.

San Diego 67

San Diego Study Report Company 67

Xconomy

NOVEMBER 26, 2018

[ Note: Ben Fidler co-authored this report.] This weekend, San Diego will host the annual American Society of Hematology conference, the largest U.S.

Guide 96

Guide San Diego Study Conference 96

Xconomy

MARCH 27, 2020

Equillium has halted two clinical trials of its lead drug candidate out of an “abundance of caution” related to the coronavirus outbreak but continues to enroll in a third, which is evaluating the antibody as a treatment for acute graft-versus-host disease.

San Diego 67

San Diego Examples Report Sites 67

Xconomy

JULY 10, 2017

TP Therapeutics, which raised $45 million in May to advance its work on drug-resistant cancers, raised the most venture capital in San Diego County during the three months that ended June 30, according to regional data released today. Altogether, venture firms invested a total of $406.4 That was down slightly from the $411.2

San Diego 58

San Diego Invest Venture Capital Startup 58

Xconomy

APRIL 15, 2019

One such fungus, Candida auris , like some bacteria, has become increasingly resistant to the drugs with which it was previously treated, causing infections across five continents, as the New York Times recently reported in an article about the rise of the “mysterious” worldwide health threat.

San Diego 81

San Diego Outsource Development Report Company 81

Xconomy

DECEMBER 4, 2018

Take the results of a Phase 3 study just reported today at the American Society of Hematology’s (ASH) yearly meeting in San Diego. The treatment landscape for multiple myeloma, a deadly cancer of the bone marrow that affects about 30,000 Americans every year, has changed significantly over the past decade.

San Diego 83

San Diego Study Report Blogging 83

Xconomy

SEPTEMBER 9, 2019

On Monday, Acadia (NASDAQ: ACAD ) reported that its drug, pimavanserin, met the goal of delaying relapse of psychosis in dementia patients compared to a placebo.

San Diego 74

San Diego Study Report Company 74

Xconomy

APRIL 6, 2020

Download the report here. Content includes: Regeneron, Moderna, and J&J’s ongoing battle against COVID-19 How governments and the private sector must step up funding coronavirus R&D efforts Lessons learned from China two months on The need to rapidly ramp-up pandemic vaccine production capacity.

Report 63

Report Invest News Content 63

Xconomy

SEPTEMBER 18, 2018

San Diego-based Viking (NASDAQ: VKTX ) reported that its drug, VK2809, hit its goals in a 12-week, Phase 2 trial of patients with nonalcoholic fatty liver disease (NAFLD) and high levels of LDL or “bad” cholesterol.

Study 76

Study San Diego Competition Report 76

Xconomy

SEPTEMBER 25, 2019

While the headlines may be dominated by news of WeWork putting its IPO on hold after reports about its questionable corporate governance, the overall initial public offering market is doing just fine.

Report 81

Report Activity News Marketing 81

Xconomy

DECEMBER 17, 2018

The news sent the San Diego, CA-based biotech’s stock plunging 40 percent. In June, the company said 10 of 37 patients with localized prostate cancer in its Phase 2b study who received the treatment reported a clinically significant response.

Slides 72

Slides San Diego Study News 72

Xconomy

APRIL 21, 2020

Two new special reports on Xconomy Insight provide an expert view on how companies can sustain clinical trials during the COVID-19 crisis.

Research 58

Research Report Technology Develop 58

Xconomy

OCTOBER 17, 2018

The pharmacy benefits manager (PBM) is excluding a new drug from Teva Pharmaceutical from coverage while favoring two rival treatments instead, according to a report from Reuters.

Report 67

Report Class Marketing San Diego 67

Xconomy

AUGUST 3, 2017

ScoreStream, a San Diego area startup providing a crowdsourced social media platform for reporting high school sports scores, said Thursday it has agreed to distribute high school game scores under a new collaboration agreement with The Associated Press.

Web 64

Web Press San Diego Social Media 64

Xconomy

OCTOBER 27, 2017

Three-year survival rates are rarely reported for a deadly form of brain cancer known as recurrent, high-grade glioma (HGG). Yet San Diego-based Tocagen (NASDAQ: TOCA ) says five patients in a high-dose cohort of its gene therapy treatment Toca 511 and Toca FC are still alive after nearly 36 months.

San Diego 75

San Diego Conference Report Company 75

Xconomy

OCTOBER 5, 2016

Venture capital activity is gradually easing from last year’s peak, according to a new quarterly report put together by Seattle-based PitchBook and the National Venture Capital Association. deals (1,796 companies) during the third quarter that ended September 30, according to the inaugural “Venture Monitor” report released today.

Venture Capital 86

Venture Capital Activity Report Funding 86

Xconomy

FEBRUARY 12, 2018

But the development of non-addictive, non-opioid pain drugs lags far behind drug R&D for other diseases ( I wrote a few months ago about why that is ), and a report from BIO released today helps quantify just how little the industry is doing in this area, and how rarely they succeed when companies do try.

Develop 73

Develop Development Report Help 73

Xconomy

JANUARY 9, 2018

Venture capital activity ended the year with a strong finish in San Diego, as investors poured $498.4 The strength of fourth-quarter deals, lifted by a $125 million financing in November for the molecular diagnostics company Progenity, brought total venture investments in San Diego to nearly $1.92

San Diego 64

San Diego Venture Capital Activity Funding 64

Xconomy

AUGUST 1, 2017

Ciara Kennedy, who succeeded Mike Grey as Amplyx CEO late last year, said in an interview with Xconomy that the company plans to report results of its Phase 1 study at IDWeek, the annual infectious diseases conference that is set for early October in San Diego. But raising $67.

San Diego 67

San Diego Study Conference Report 67